==== Front BMC Infect Dis BMC Infect Dis BMC Infectious Diseases 1471-2334 BioMed Central London 8420 10.1186/s12879-023-08420-8 Research Bacterial findings in patients referred to hospital for the treatment of acute tonsillitis with or without peritonsillar phlegmon http://orcid.org/0000-0002-0276-8529 Andersen Camilla camiande@rm.dk 1 Greve Thomas 1 Reinholdt Kasper Basse 2 Kjaerulff Ann Marlene Gram 2 Udholm Nichlas 2 Khalid Vesal 2 Madzak Adnan 2 Duez Christophe 2 Münch Henrik 2 Pauli Søren 23 Danstrup Christian Sander 3 Petersen Niels Krintel 23 Klug Tejs Ehlers 24 1 grid.154185.c 0000 0004 0512 597X Department of Clinical Microbiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99 Aarhus N, Aarhus, DK-8200 Denmark 2 grid.154185.c 0000 0004 0512 597X Department of Otorhinolaryngology, Head & Neck Surgery, Aarhus University Hospital, Aarhus, Denmark 3 grid.27530.33 0000 0004 0646 7349 Department of Otorhinolaryngology, Head & Neck Surgery, Aalborg University Hospital, Aalborg, Denmark 4 grid.7048.b 0000 0001 1956 2722 Aarhus University, Aarhus, Denmark 29 6 2023 29 6 2023 2023 23 43910 3 2023 22 6 2023 © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Background The vast majority of patients with acute tonsillitis (AT) are managed in general practice. However, occasionally patients are referred to hospital for specialized management because of aggravated symptoms and/or findings suggestive of peritonsillar involvement. No prospective studies have been conducted aiming to investigate the prevalent and significant microorganisms in this highly selected group of patients. We aimed to describe the microbiological findings of acute tonsillitis with or without peritonsillar phlegmon (PP) in patients referred for hospital treatment and to point out potential pathogens using the following principles to suggest pathogenic significance: (1) higher prevalence in patients compared to healthy controls, (2) higher abundance in patients compared to controls, and (3) higher prevalence at time of infection compared to time of follow up. Methods Meticulous and comprehensive cultures were performed on tonsillar swabs from 64 patients with AT with (n = 25) or without (n = 39) PP and 55 healthy controls, who were prospectively enrolled at two Danish Ear-Nose-Throat Departments between June 2016 and December 2019. Results Streptococcus pyogenes was significantly more prevalent in patients (27%) compared to controls (4%) (p < 0.001). Higher abundance was found in patients compared to controls for Fusobacterium necrophorum (mean 2.4 vs. 1.4, p = 0.017) and S. pyogenes (mean 3.1 vs. 2.0, p = 0.045) in semi-quantitative cultures. S. pyogenes, Streptococcus dysgalactiae, and Prevotella species were significantly more prevalent at time of infection compared to follow up (p = 0.016, p = 0.016, and p = 0.039, respectively). A number of species were detected significantly less frequently in patients compared to controls and the mean number of species was significantly lower in patients compared to controls (6.5 vs. 8.3, p < 0.001). Conclusions Disregarding Prevotella spp. because of the prevalence in healthy controls (100%), our findings suggest that S. pyogenes, F. necrophorum, and S. dysgalactiae are significant pathogens in severe AT with or without PP. In addition, infections were associated with reduced diversity (dysbacteriosis). Trial registration The study is registered in the ClinicalTrials.gov protocol database (# 52,683). The study was approved by the Ethical Committee at Aarhus County (# 1-10-72-71-16) and by the Danish Data Protection Agency (# 1-16-02-65-16). Supplementary Information The online version contains supplementary material available at 10.1186/s12879-023-08420-8. Keywords Streptococcus pyogenes Fusobacterium necrophorum Streptococcus dysgalactiae Dysbacteriosis http://dx.doi.org/10.13039/100007606 Aarhus Universitetshospital http://dx.doi.org/10.13039/501100003554 Lundbeckfonden R185-2014-2482 Ørelæge Hans Skovby’s og Hustru Emma Skouby’s Fondhttp://dx.doi.org/10.13039/501100008249 Frimodt-Heineke Fonden http://dx.doi.org/10.13039/501100007436 Torben og Alice Frimodts Fond issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2023 ==== Body pmcIntroduction Acute tonsillitis (AT) is a very frequent reason for consultation in general practice [1]. The majority of patients have uncomplicated, self-limiting disease and do not require antibiotic treatment [2]. Streptococcus pyogenes is considered the prevalent bacterial cause of AT [3]. In Denmark and most of the world, it is common only to investigate for the presence of S. pyogenes in throat swabs and often only by the use of a rapid antigen detection test [4]. However, studies also suggest that Streptococcus dysgalactiae, Arcanobacterium haemolyticum [5], and (more recently) Fusobacterium necrophorum may be important pathogens in AT [6–8]. The vast majority of patients with AT are managed in general practice, but approximately 300 patients are annually referred to the Ear-Nose-Throat Departments at Aarhus University Hospital and Aalborg University Hospital for more specialized treatment. Hence, referred patients constitute a highly selected subgroup of patients with AT either with severe symptoms or signs of peritonsillar phlegmon (PP). This subgroup of patients with severe throat infections are treated with antibiotics without prior microbiological investigations as they are considered to be bacterially infected. A few studies of hospitalized patients with AT describe the bacteriological findings in routine cultures [9–11], but no prospective studies have been conducted aiming to investigate the prevalent and significant microorganisms in this highly selected group of patients with severe AT. The current study was undertaken to: (1) describe the microorganisms found in AT with or without PP referred for treatment in a hospital setting using meticulous and comprehensive aerobic and anaerobic culture methods, and (2) investigate which of the cultured microorganisms are likely pathogens. Materials and methods Participants Patients Patients were prospectively enrolled in the period June 2016 - December 2019 at two Danish Departments of Otorhinolaryngology, Head and Neck Surgery (Aarhus University Hospital and Aalborg University Hospital). The inclusion criteria were: (1) patients with AT with or without PP referred for hospitalization or outpatient treatment, (2) age 15–40 years, (3) Centor Score 3–4, and (4) written and oral consent. The exclusion criteria were: (1) peritonsillar abscess (PTA), (2) acute or previous tonsillectomy, and (3) biochemical signs of infectious mononucleosis. No screening log for in- and exclusion of patients were performed. AT was defined as anamnestic sore throat and pain on swallowing in addition to visual inflammation of the tonsillar mucosa. PP was defined as the clinical finding of swelling of the peritonsillar tissue without detection of peritonsillar pus. PTA was defined as visual detection of peritonsillar pus. Healthy controls With an aim to pinpoint the likely pathogens in AT, healthy controls (medical students) fulfilling the following criteria were enrolled in the period March - May 2022 as reference group: (1) age 15–40 years, (2) no symptoms or signs of acute throat infection within the last three months, (3) no more than three throat infections within the last two years, (4) no antibiotic treatment within the last three months, and (5) no previous tonsillectomy. Sample collection Patients At the time of acute examination, a tonsillar swab (E-swab (Copan, Brescia, Italy)) from both tonsillar surfaces and blood samples for biochemical analysis were obtained. Patients were invited to a follow up examination two to four weeks later, where another tonsillar swab was obtained. The tonsillar swabs were placed at -80 °C within 30 min of collection. Healthy controls Tonsillar swabs were obtained and processed in the same way as for the patients. Microbiological analyses Samples were processed in a class 2 laminar air flow safety cabinet using an aseptic technique. Swabs were vortexed for 5 s. and the flocked swab was discharged. 10 µL of liquid medium was plated on 5% horse blood agar, chocolate agar, Mueller Hinton agar with 5% horse blood and 20 mg/L NAD plus selected antimicrobial discs used for initial differentiation of bacterial species, anaerobic agar (chocolate plate containing K-vitamin and cysteine), and selective Fusobacterium agar (containing 5 mg/L nalidixic acid and 2.5 mg/L vancomycin) (Statens Serum Instutite Diagnostica, Hillerød, Denmark). Plates were incubated at 35 °C, the first three plates in 5% CO2, and the latter two plates in anaerobic atmosphere including a metronidazole-disc (10 UG) (Oxiod, Roskilde, Denmark). All plates were incubated for 4 days, but also checked for growth after 2 days. Cultured microorganisms were initially identified to genus-level by phenotypic appearance and biochemical profiles according to accepted guidelines [12] and for several bacteria matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Bremen, Germany) was used to obtain species-level identification (see Additional file 1 in supplementary). Species differentiation between the closely related Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus is inadequate by phenotypic appearance, MALDI-TOF MS, and 16 S rDNA gene fragment analysis and is thus referred to as Streptococcus anginosus group. The initial criteria for anaerobic bacteria were growth in anaerobic atmosphere and sensitivity towards metronidazole. The microorganism colony count was reported semi-quantitatively and divided into the following four different categories according to the quantification; 1: 1 colony, 2: 2–49 colonies, 3: 50–500 colonies, and 4: >500 colonies. Criteria for pathogenic significance The following principles to suggest pathogenic significance of identified microorganisms were used in the present study: (1) higher prevalence in patients compared to healthy controls, (2) higher abundance (semi-quantitative count) in patients compared to controls, and (3) higher prevalence at time of infection compared to time of follow up. Statistical analyses Statistical analyses were performed using the Fisher’s exact test for categorical variables (sex, smoking, prevalence), the Student’s t-test for continuous variables (age and number of species), the Kruskal-Wallis test for non-parametric variables (semi-quantitative count), and binomial probability test for comparison of number of isolates at time of infection vs. follow up. Statistical significance was defined as p < 0.05. Permissions The study is registered in the ClinicalTrials.gov protocol database (Unique Protocol ID: 52,683). The study was approved by the Ethical Committee at Aarhus County (# 1-10-72-71-16) and by the Danish Data Protection Agency (# 1-16-02-65-16). Informed consent was obtained from all patients in accordance with the guidelines set by the Danish National Board of Health. Results Patient characteristics A total of 64 patients and 55 healthy controls were enrolled in the study. There was no statistically significant difference in sex and age between patients (38% males, mean age 26 years) and controls (51% males, mean age 26 years) (p = 0.19, Fisher´s exact test and p = 0.44, Student’s t-test, respectively). Significantly more patients admitted to smoking (41%) compared to controls (4%) (p < 0.001, Fisher´s exact test) (Table 1). Table 1 Clinical and biochemical characteristics of 64 patients with acute tonsillitis with or without peritonsillar phlegmon (PP) and 55 healthy controls Primary infection Acute tonsillitis All n = 64 Without PP n = 39 With PP n = 25 Controls n = 55 Males 24 (38%) 12 (31%) 12 (48%) 28 (51%) Age, mean (SD) 25.7 (5.6) 26.4 (5.4) 24.4 (5.8) 26.3 (1.4) Duration of symptoms, days median (range) 4.0 (1.0–13.0) 3.0 (1.0–12.0) 5.0 (1.0–13.0) Reasons for referral Suspected peritonsillar abscess 48 (75%) 23 (59%) 25 (100%) Dehydration 14 (22%) 12 (31%) 2 (8%) Pain 23 (36%) 18 (46%) 5 (20%) Other1 6 (9%) 5 (13%) 1 (4%) Antibiotic treatment prior to admission 32 (50%)2 20 (51%) 12 (44%) Tobacco smoking (current) 26 (41%) 18 (47%) 8 (32%) 2 (4%) Temperature, mean oC (SD) 38.4 (0.8) 38.4 (0.9) 38.3 (0.8) Biochemistry, mean (SD) C-reactive protein, mg/L 167.0 (112.7) 177.7 (110.5) 150.1 (116.3) Leukocyte count, x109/L 14.6 (5.0) 14.0 (5.5) 15.7 (4.0) Neutrophil count, x109/L 11.6 (4.7) 10.9 (5.2) 12.7 (3.8) Lymphocyte count, x109/L 1.6 (0.7) 1.6 (0.8) 1.5 (0.4) 1 Dyspnoea/upper airway obstruction (n = 3), General malaise (n = 1), Neck swelling (n = 1), Lack of improvement after antibiotic treatment (n = 1) 2 Phenoxymethyl-penicillin (n = 29) or amoxicillin-clavulanic acid (n = 3) Based on clinical findings, 39 (61%) patients were categorized as AT without PP and 25 (39%) patients with PP. In addition to sore throat and pain on swallowing, patient´s symptoms included anamnestic fever (91%) and otalgia (78%). Frequent clinical findings were swollen tonsils (95%), sore cervical lymph nodes (95%), tonsillar exudates (75%), and fever (> 38.0oC) (65%). The prevalent reasons for referral to hospital were suspected PTA (73%), pain (36%), and dehydration (22%) (Table 1). Antibiotics were prescribed to 32 (50%) of patients prior to admission; the vast majority (29/32) were treated with phenoxymethyl-penicillin. Thirty-nine (61%) patients were hospitalized for the following reasons: intravenous antibiotic treatment (95%), pain management (72%), rehydration (67%), peritonsillar infection (36%), and/or respiratory distress (5%). The remaining 25 patients (39%) were treated in the outpatient clinic. All patients were treated with antibiotics after admission, either in hospital or as outpatient treatment, of which 59% (38/64) received benzyl-penicillin and 34% (22/64) received phenoxymethyl-penicillin. Culture findings The culture findings in tonsillar swabs from patients and controls are shown in Table 2. The most prevalent isolates in patients were non-hemolytic streptococci (98%), Prevotella spp. (83%), Rothia spp. (77%), Corynebacterium spp. (72%), and Neisseria spp. (64%). Similarly, the most prevalent isolates in controls were genera belonging to the commensal pharyngeal flora: non-hemolytic streptococcus (100%), Prevotella spp. (100%), Neisseria spp. (96%), Rothia spp. (82%), Haemophilus parainfluenzae (69%), and Corynebacterium spp. (56%). The mean number of species cultured from tonsillar swabs obtained from patients (6.5) was significantly lower compared to controls (8.3) (p < 0.001, Student’s t-test). Table 2 Culture findings in tonsillar surface swabs from 64 patients with acute tonsillitis with or without peritonsillar phlegmon (PP) and 55 healthy controls Primary infection Acute tonsillitis All n = 64 Without PP n = 39 With PP n = 25 Controls n = 55 Microorganisms Aerobic bacteria Streptococcus pyogenes 17 (27%) 8 (21%) 9 (36%) 2 (4%) Streptocoocus dysgalactiae 7 (11%) 4 (10%) 3 (12%) 3 (5%) Streptococcus anginosus group 5 (8%) 4 (10%) 1 (4%) 5 (9%) Non-hemolytic streptococci 63 (98%) 38 (97%) 25 (100%) 55 (100%) Haemophilus influenzae 1 (2%) 1 (3%) 1 (2%) Haemophilus parainfluenzae 16 (25%) 9 (23%) 7 (28%) 38 (69%) Haemophilus spp. 1 (2%) 1 (3%) 13 (24%) Staphylococcus aureus 17 (27%) 10 (26%) 7 (28%) 22 (40%) Coagulase-negative staphylococci 5 (8%) 4 (10%) 1 (4%) 3 (5%) Eikenella corrodens 8 (13%) 6 (15%) 2 (8%) 2 (4%) Neisseria spp. 41 (64%) 26 (67%) 15 (60%) 53 (96%) Corynebacterium spp. 46 (72%) 26 (67%) 20 (80%) 31 (56%) Rothia spp. 49 (77%) 33 (85%) 16 (64%) 45 (82%) Aggregatibacter aphrophilus 1 (2%) Moraxella catarrhalis 1 (2%) 1 (3%) Enterobacteriaceae 1 (2%) Gemella spp. 1 (2%) Granulicatella adiacens 3 (5%) 3 (12%) Anaerobic bacteria Fusobacterium necrophorum 7 (11%) 2 (5%) 5 (20%) 5 (9%) Fusobacterium spp. 2 (3%) 2 (5%) 17 (31%) Prevotella spp. 53 (83%) 31 (79%) 22 (88%) 55 (100%) Veillonella spp. 26 (41%) 16 (41%) 10 (40%) 22 (40%) Leptotrichia spp. 5 (8%) 1 (3%) 4 (16%) 25 (45%) Lactobacillus spp. 13 (20%) 8 (21%) 5 (20%) 6 (11%) Actinomyces odontolyticus 11 (17%) 7 (18%) 4 (16%) 20 (36%) Actinomyces spp. 8 (13%) 5 (13%) 3 (12%) 12 (22%) Capnocytophaga spp. 1 (2%) Lachnoanaerobaculum orale 1 (2%) 1 (4%) 9 (16%) Campylobacter spp. 1 (2%) 1 (3%) 1 (2%) Dialister spp. 2 (3%) 2 (5%) Propionibacterium acnes 1 (2%) 1 (4%) Anaerobes (unspecified) 3 (5%) 2 (5%) 1 (4%) 8 (15%) Fungi Candida 5 (8%) 2 (5%) 3 (12%) 1 (2%) Number of species, mean (SD) 6.5 (1.6) 6.4 (1.5) 6.7 (1.6) 8.3 (1.4) S. pyogenes was significantly more prevalent in patients (27%) compared to controls (4%) (p < 0.001, Fisher´s exact test). The following species were significantly less frequently cultured in patients compared to controls: H. parainfluenzae (25% vs. 69%, p < 0.001), Haemophilus spp. (2% vs. 24%, p < 0.001), Neisseria spp. (64% vs. 96%, p < 0.001), Fusobacterium spp. (3% vs. 31%, p < 0.001), Prevotella spp. (83% vs. 100%, p < 0.001), Leptotrichia spp. (8% vs. 45%, p < 0.001), Actinomyces odontolyticus (17% vs. 36%, p = 0.022), and Lachnoanaerobaculum orale (2% vs. 16%, p = 0.006) (Table 2). Semi-quantitative analyses Although, there was no significant difference in F. necrophorum between patients and controls (11% vs. 9%, p = 0.77) (Table 2), semi-quantitative culture findings showed significantly higher abundance of F. necrophorum in patients compared to the controls (2.4 vs. 1.4, p = 0.017, Kruskal Wallis-test). In addition, S. pyogenes was also cultured in significantly higher abundance in patients compared to controls (3.1 vs. 2.0, p = 0.045), while Neisseria spp. was isolated in significantly less abundance in patients than controls (2.4 vs. 2.6, p = 0.015) (Table 3). Table 3 Semi-quantitative culture findings in tonsillar surface swabs from 64 patients with acute tonsillitis with or without peritonsillar phlegmon (PP) and 55 healthy controls. Means (SD) are given All n = 64 Controls n = 55 p1 Microorganisms Aerobic bacteria Streptococcus pyogenes 3.1 (0.7) 2.0 (0.0) 0.045 Streptococcus dysgalactiae 3.4 (1.0) 2.7 (0.6) 0.17 Streptococcus anginosus group 2.8 (1.1) 2.2 (0.4) 0.37 Non-hemolytic streptococci 3.4 (0.6) 3.3 (0.5) 0.43 Haemophilus influenzae 2.0 (----) 2.0 (----) - Haemophilus parainfluenzae 2.3 (0.4) 2.1 (0.3) 0.18 Haemophilus spp. 2.0 (----) 2.2 (0.4) 0.60 Staphylococcus aureus 2.4 (0.8) 2.3 (0.5) 0.94 Coagulase-negative staphylococci 2.2 (0.4) 2.0 (0.0) 0.44 Eikenella corrodens 2.4 (0.5) 2.0 (0.0) 0.33 Neisseria spp. 2.4 (0.7) 2.6 (0.6) 0.015 Corynebacterium spp. 2.3 (0.5) 2.2 (0.4) 0.15 Rothia spp. 2.9 (0.7) 2.7 (0.7) 0.20 Aggregatibacter aphrophilus 2.0 (----) - Moraxella catarrhalis 2.0 (----) - Enterobacteriaceae 2.0 (----) - Gemella spp. 2.0 (----) - Granulicatella adiacens 2.0 (0.0) - Anaerobic bacteria Fusobacterium necrophorum 2.4 (0.5) 1.4 (0.5) 0.017 Fusobacterium spp. 2.0 (0.0) 2.0 (0.0) - Prevotella spp. 2.8 (0.5) 2.8 (0.5) 0.94 Veillonella spp. 2.2 (0.4) 2.0 (0.2) 0.23 Leptotrichia spp. 2.2 (0.4) 2.0 (0.0) 0.49 Lactobacillus spp. 2.0 (0.0) 2.0 (0.0) - Actinomyces odontolyticus 2.5 (0.5) 2.4 (0.5) 0.47 Actinomyces spp. 2.5 (0.5) 2.3 (0.5) 0.30 Capnocytophaga spp. 2.0 (----) - Lachnoanaerobaculum orale 4.0 (----) 2.1 (0.3) - Campylobacter spp. 2.0 (----) 2.0 (----) - Dialister spp. 2.0 (0.0) - Anaerobes (unspecified) 2.0 (0.0) 2.0 (0.0) - Fungi Candida 2.0 (0.0) 2.0 (----) - Semi-quantitative count: 1: 1 colony, 2: 2–49 colonies, 3: 50–500 colonies, 4: >500 colonies 1 Kruskal-Wallis test Impact of antibiotic treatment prior to admission No statistically significant difference in mean number of species cultured (6.3 vs. 6.8, p = 0.17, Student’s t-test) was found between patients with or without antibiotic treatment prior to admission. With the exception of Haemophilus influenzae (25% vs. 12%, p = 0.02, Fisher´s exact test), no statistically significant differences were found in culture rates among other species in patients with or without antibiotic treatment prior to admission (data not shown). Time of infection and follow up Tonsillar swabs were obtained from 41 (64%) patients at follow up (mean 23 days after admission (range 11–56 days)). The clinical and biochemical characteristics of patients with and without follow up culture resembled each other (apart from the proportion of patients, who were referred because of pain, see Additional file 2 in supplementary). The mean number of species cultured were significantly lower at time of infection (6.5) compared to follow up (7.5) (p = 0.006, Student’s t-test), which was significantly lower compared to controls (8.3) (p = 0.006) (Table 4). Table 4 Culture findings in tonsillar surface swabs from 41 patients with acute tonsillitis with or without peritonsillar phlegmon obtained at time of infection and at follow up (11–56 days later) Obtained from cultures at time of infection only Obtained from cultures at time of infection and follow up Obtained from follow up cultures only p1 Microorganisms Aerobic bacteria Streptococcus pyogenes 7 (17%) 1 (2%) 0.016 Streptococcus dysgalactiae 7 (17%) 0.016 Streptococcus anginosus group 1 (2%) 1 (2%) 5 (12%) 0.22 Non-hemolytic streptococci 40 (98%) 1 (2%) 1.00 Haemophilus influenzae 1 (2%) 1.00 Haemophilus parainfluenzae 5 (12%) 7 (17%) 20 (49%) 0.004 Haemophilus spp. 1 (2%) 1 (2%) 1.00 Staphylococcus aureus 6 (15%) 5 (12%) 2 (5%) 0.29 Coagulase-negative staphylococci 2 (5%) 2 (5%) 6 (15%) 0.29 Eikenella corrodens 5 (12%) 1 (1%) 3 (7%) 0.73 Neisseria spp. 7 /17%) 18 (44%) 9 (22%) 0.80 Corynebacterium spp. 5 (12%) 23 (56%) 11 (27%) 0.21 Rothia spp. 1 (2%) 28 (68%) 12 (29%) 0.003 Moraxella catarrhalis 1 (2%) 1.00 Actinetobacter spp. 1 (2%) 1.00 Pseudomonas spp. 1 (2%) 1.00 Gemella spp. 3 (7%) 0.25 Granulicatella adiacens 3 (7%) 0.25 Leuconostoc spp. 1 (2%) 1.00 Anaerobic bacteria Fusobacterium necrophorum 4 (10%) 0.13 Fusobacterium spp. 1 (2%) 3 (7%) 0.63 Prevotella spp. 10 (24%) 25 (61%) 2 (5%) 0.039 Veillonella spp. 6 (15%) 12 (29%) 10 (24%) 0.45 Leptotrichia spp. 2 (5%) 2 (5%) 8 (20%) 0.11 Lactobacillus spp. 2 (5%) 4 (10%) 8 (20%) 0.11 Actinomyces odontolyticus 6 (15%) 2 (5%) 9 (22%) 0.61 Actinomyces spp. 5 (12%) 2 (5%) 7 (17%) 0.77 Capnocytophaga spp. 5 (12%) 0.063 Lachnoanaerobaculum orale 3 (7%) 0.25 Campylobacter spp. 1 (2%) 1.00 Dialister spp. 2 (5%) 0.50 Anaerobes (unspecified) 1 (2%) 1.00 Parvimonas micra 1 (2%) 1.00 Propionibacterium acnes 1 (2%) 1.00 Fungi Candida 2 (5%) 0.50 Number of species, mean (SD) 6.5 (1.7) 7.5 (1.6) 0.006 1 Binomial probability test (number at time of infection vs. at time of follow up), except for number of species (Student´s t-test) The following species were significantly more prevalent in cultures at time of infection compared to follow up: S. pyogenes (17% vs. 0%, p = 0.016, binomial probability test), S. dysgalactiae (17% vs. 0%, p = 0.016), and Prevotella spp. (24% vs. 6%, p = 0.039). On the contrary, the following species were cultured significantly less frequent at time of infection compared to follow up: H. parainfluenzae (12% vs. 49%, p = 0.004) and Rothia spp. (2% vs. 29%, p = 0.003). F. necrophorum, H. influenzae, Moraxella catarrhalis, Granulicatella adiacens, Dialister spp., and Candida were found at time of infection only (Table 4). No statistically significant differences in semi-quantitative abundance were found for the different species at time of infection compared to follow up (data not shown). Discussion Patient characteristics The 64 patients included in the present study constitute a highly selected group of patients with severe AT with or without peritonsillar involvement, but without abscess formation, who were referred from general practice for specialized management by oto-rhino-laryngologists. The patients had substantial symptoms of AT, clear clinical signs of infection, and highly elevated C-reactive protein (mean: 167 mg/L) and neutrophil count (mean: 11.6 × 109/L) suggestive of bacterial infection. Hence, the included patients had an urgent need for treatment and the suspicion of bacterial aetiology was very high. However, no prospective studies have been conducted exploring the significant pathogens in this group of patients. Based on tradition and the knowledge on the importance of S. pyogenes in AT, penicillin (benzyl- or phenoxymethyl-) is the standard antibiotic treatment for severe AT in Denmark. Suggested significant pathogens Using meticulous and comprehensive culture methods, abundant polymicrobial aerobic and anaerobic flora was found in tonsillar swabs from AT patients as well as healthy controls. Based on the relative prevalence and semi-quantitative abundance between patients (at time of infection and follow up) and controls, pathogenic significance for the following bacteria was suggested: S. pyogenes, F. necrophorum, and S. dysgalactiae. S. pyogenes was the only bacteria cultured with both significantly higher prevalence (17% vs. 4%) and semi-quantitative abundance (3.1 vs. 2.0) in patients compared to controls in addition to higher prevalence at time of infection than follow up (17% vs. 0%). These findings are in line with previous studies of patients with pharyngeal infections from uncomplicated AT [3] to PTA [13–15], and parapharyngeal abscesses [16]. The proportion of S. pyogenes-carriage in healthy individuals vary in different studies. In line with our findings, mean carriage-rates of 2.8% in adults and 8.0% in children were reported by Oliver et al. in a meta-analysis [17]. F. necrophorum was cultured in significantly higher abundance in patients compared to controls (2.4 vs. 1.4). The role of F. necrophorum in AT is unclarified [18], but more studies suggest that this anaerobe may play a role in uncomplicated cases. In PTA, F. necrophorum is established as the prevalent pathogen, while the importance in parapharyngeal abscesses is less certain [13, 15, 16]. In the current study, S. dysgalactiae was more prevalent at time of infection (17%), than at follow up (0%). A few previous studies have investigated the role of S. dysgalactiae in AT. A meta-analysis from 2020 to 11 studies suggested an association between Streptococcus group C (S. dysgalactiae) and uncomplicated sore throat in adults, even though it was much less evident than for S. pyogenes [19]. Lindbæk and colleagues investigated the role of S. dysgalactiae versus S. pyogenes in 306 patients with AT and found that 48% of the S. pyogenes-positive patients and 45% of the S. dysgalactiae-positive patients met three or four of the Centor criteria [20]. They concluded that S. dysgalactiae should be considered as a throat pathogen in line with S. pyogenes. In a study of 3,700 AT patients treated in primary health care, Nygren et al. found lower complication rates among patients positive for Group C/G streptococci (16%) compared to those positive for S. pyogenes (28%) and F. necrophorum (26%) [21]. Prevotella spp. was significantly more prevalent at time of infection (85%) compared to follow up (66%). However, this anaerobe was cultured from all controls (100%), suggesting that Prevotella spp. is part of commensal tonsillar flora and that the relatively low culture rate at follow up reflects the disturbed tonsillar flora at this time point. Based on these findings, we did not include Prevotella spp. among bacteria with suggested pathogenicity in AT. Brook and colleagues have conducted a number of serological studies showing increased antibody levels to Prevotella intermedia in patients with AT, peritonsillar cellulitis, infectious mononucleosis, PTA, and recurrent non-streptococcal tonsillitis [22–25]. More recently, our group conducted a prospective study of 60 patients with parapharyngeal abscesses [16]. Prevotella spp. was found in 12% of pus swabs, often in absolute and/or relative abundance and we concluded that this anaerobe was among four suggested significant pathogens. In a similar, comparative study aimed to identify the significant pathogens in PTA, S. pyogenes and F. necrophorum were isolated significantly more frequently (both in tonsillar cores and surface swabs) among 36 patients than 80 controls, while Group C/G streptococci were found equally often [14]. Despite a meticulous and comprehensive culture and identification process, the three suggested pathogens in AT (S. pyogenes, F. necrophorum and S. dysgalactiae) were only detected in 48% of patients, leaving 52% of patients without suggested bacterial pathogens. Patients with no suggested pathogens were more frequently treated with antibiotics prior to admission (64% vs. 32%, p = 0.014, Fisher´s exact test), had longer duration of symptoms (median: 4.0 vs. 3.0 days, p = 0.034, Kruskal-Wallis test), and had lower (though still elevated) leukocyte and neutrophil counts (means: 12.1 vs. 17.1 and 9.2 vs. 13.9 × 109/L, respectively, both p < 0.001) compared to patients with one of the three pathogens cultured. An interpretation could be that patients, who have had symptoms for longer were more likely to receive antibiotics, which in turn reduced the chance of culturing the three penicillin-susceptible pathogens in question. Another interpretation could be that patients without one of the three pathogens were infected with a virus or a less violent bacterium. The substantial symptoms and findings in addition to the elevated infection markers brings the authors to find the first interpretation most likely. Dysbacteriosis The mean number of species cultured was significantly lower in patients at time of infection compared to controls (6.5 vs. 8.3) and the following species, belonging to the commensal pharyngeal flora, were detected significantly less frequently: Prevotella spp., Rothia spp., Neisseria spp., H. parainfluenzae, Leptotrichia spp., Fusobacterium spp., Haemophilus spp., and Lachnoanaerobaculum orale. After clinical recovery, the number of species cultured increased at follow up (mean 7.3) suggesting a trend towards normalization of the pharyngeal flora. Hence, infections were not only associated with increased presence of a few potential pathogens, but a reduced diversity of the pharyngeal flora (dysbacteriosis) was also evident. Dysbacteriosis is well-described in other human body sites where microorganisms (microbiota) live in communities on the skin surface or mucosal membrane (e.g. the oral cavity and the gastrointestinal tract). The composition of the microbiota is affected by the environment and antibiotic treatment, smoking, increasing age, and a number of diseases have been shown to cause alterations in the microbial composition and diversity [26, 27]. Whether the observed dysbacteriosis in the current study is secondary to AT or a factor paving the road for the invasive bacteria is speculative. Previous studies on patients referred to hospital with acute tonsillitis To our knowledge, the current study is the first to prospectively investigate the culturable microorganisms among patients with AT with or without PP referred for treatment in a hospital setting. A few previous retrospective studies have described the bacteriological findings in routine cultures with no further attempts to identify the significant pathogens [9–11]. Rusan et al. detected S. pyogenes (23%), S. dysgalactiae (11%), and F. necrophorum (5%) in 109 throat swabs from 327 patients [9]. Suzuki et al. included 127 AT patients from 36 Ear-Nose-Throat departments and clinics. Bacterial cultures from throat swabs showed; S. pyogenes (12%), Staphylococcus aureus (3%), Streptococcus pneumonia (2%), and H. influenza (1%) [11]. It was not stated whether patients were hospitalized or treated in an outpatient setting. Lastly, Risberg et al. detected S. pyogenes in 35 of 102 patients with PP using a rapid antigen detection test. No further bacterial investigations were made [10]. Limitations Our conclusions concerning the significant pathogens associated with severe AT should be interpreted in light of the relatively limited number of patients and controls (risk of type II errors). The study relies on bacterial cultivation and swabs were frozen before processing, which may affect the ability to culture some fastidious or fragile microorganisms. The following precautions were made to minimize processing bias: (1) samples were rapidly transferred to -80 °C after collection. (2) a broad range of aerobic and anaerobic plate media were used to attempt exhaustive cultivation. (3) the same very experienced technician processed all samples. In addition, MALDI-TOF MS was used for accurate identification. However, an exhaustive species distinction using cultured-based methods is difficult and some species may have been un- or under-detected [28, 29]. Medical students were used as healthy controls. Though their ages and gender-ratio matched the patients well, controls were less often smokers and may not represent a normative population. However, the swabs were obtained and processed in the same way as for patients and our findings (S. pyogenes 4%, F. necrophorum 9%, and S. dysgalactiae 5%) are similar to previously reported culture-based detection rates for the suggested pathogens (S. pyogenes 1.1–2.3%, F. necrophorum 3.8–9.4%, and S. dysgalactiae 3.1–5.5%) [6, 17–[18, 30]–31]. Studies using polymerase chain reaction (PCR) methodology have reported higher detection rates with low quantities of bacteria present in the samples [30, 32], which is in agreement with our finding of significantly less abundance (semi-quantitative count) of S. pyogenes and F. necrophorum in controls compared to patients. Lastly, multiple comparisons were made in the study and it could be argued that correction for multiple testing is appropriate. Such correction was not applied as our conclusions concern three bacteria, which have previously been suggested as pathogens in AT and, thus, the uncorrected statistically significant findings are unlikely to be results of chance. However, the p-values should be interpreted in light of the multiple comparisons made. Conclusion Our findings suggest that S. pyogenes, F. necrophorum, and S. dysgalactiae are significant pathogens in severe AT with or without PP. In addition, infections were associated with reduced diversity (dysbacteriosis). Based on the fact that all three suggested pathogens are sensitive to penicillin, we advocate the use of phenoxymethyl-penicillin or benzyl-penicillin for the treatment of patients, who are referred to hospital with AT or PP. Further investigations with non-culture-based methods such as whole genome sequencing or microbiome analyses may provide more detailed information on the causative microorganisms within this group of patients. Electronic supplementary material Below is the link to the electronic supplementary material. Additional file 1. Clinical and biochemical characteristics of 64 patients with or without follow up cultures. Additional file 2. Methods used for identification of bacteria. Acknowledgements Not applicable. Authors’ contributions CA and TG: Design and conduction of microbiological analyses; analysis and interpretation of the results; critical revision; drafting and approval of the manuscript; accountable for all aspects of the work. KBR, AGK, NU, VK, AM, CDZ, HM, SP, CDP, and NKP: Inclusion of patients; critical revision; approval of the manuscript; accountable for all aspects of the work. TEK: Initiation and design of the study; inclusion of patients; analysis and interpretation of the results; drafting and approval of the manuscript; accountable for all aspects of the work. Funding This work was supported by a grant from Aarhus University Hospital, the Lundbeck Foundation [Grant number: R185-2014-2482], Ørelæge Hans Skovby´s og Hustru Emma Skouby´s Fond, Frimodt-Heineke Fonden, and Torben og Alice Frimodts Fond. Data Availability Anonymized data can be obtained from the corresponding author upon request. Declarations Ethics approval and consent to participate The study was approved by the Ethical Committee of Aarhus County (#1-10-72-71-16). Informed consent was obtained from all patients. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interest. Abbreviations AT Acute tonsillitis PP Peritonsillar phlegmon PTA Peritonsillar abscess MALDI-TOF MS Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry PCR Polymerase chain reaction Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. ==== Refs References 1. Schappert SM Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996 Vital Health Stat 1998 13 134 1 37 2. Gunnarson RK Ebell M Centor R Little P Verheij T Lindbæk M Sundvall PD Best management of patients with an acute sore throat – a critical analysis of current evidence and a consensus of experts from different countries and traditions Infect Dis 2023 27 1 12 10.1080/23744235.2023.2191714 3. Windfuhr JP Toepfner N Steffen G Waldfahrer F Berner R Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management Eur Arch Otorhinolaryngol 2016 273 4 973 87 10.1007/s00405-015-3872-6 26755048 4. ESCMID Sore Throat Guideline GroupPelucchi C Grigoryan L Galeone C Esposito S Huovinen P Little P Verheij T Guideline for the management of acute sore throat Clin Microbiol Infect 2012 18 Suppl 1 1 28 10.1111/j.1469-0691.2012.03766.x 5. Meier FA Centor RM Graham L Jr Dalton HP Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci Arch Intern Med 1990 150 4 825 9 10.1001/archinte.1990.00390160081017 2327842 6. Hedin K Bieber L Lindh M Sundqvist M The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium necrophorum is commonly found Clin Microbiol Infect 2015 21 3 263 10.1016/j.cmi.2014.08.020 7. Jensen A Hansen TM Bank S Kristensen LH Prag J Fusobacterium necrophorum tonsillitis: an important cause of tonsillitis in adolescents and young adults Clin Microbiol Infect 2015 21 3 266 10.1016/j.cmi.2014.09.020 8. Kjærulff AM Thomsen MK Ovesen T Klug TE Clinical and biochemical characteristics of patients with Fusobacterium necrophorum-positive acute tonsillitis Eur Arch Otorhinolaryngol 2015 272 6 1457 63 10.1007/s00405-015-3535-7 25876001 9. Rusan M Klug TE Ovesen T An overview of the microbiology of acute ear, nose and throat infections requiring hospitalisation Eur J Clin Microbiol Infect Dis 2009 28 3 243 51 10.1007/s10096-008-0619-y 18830726 10. Risberg S Engfeldt P Hugosson S Peritonsillar abscess and cellulitis and their relation to a positive antigen detection test for streptococcal infection Scand J Infect Dis 2010 42 10 747 51 10.3109/00365548.2010.490236 20515290 11. Suzuki K Kurono Y Ikeda K Hotomi M Yano H Watanabe A Matsumoto T Takahashi Y Hanaki H The seventh nationwide surveillance of six otorhinolaryngological infectious diseases and the antimicrobial susceptibility patterns of the isolated pathogens in Japan J Infect Chemother 2020 26 9 890 9 10.1016/j.jiac.2020.05.020 32622623 12. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML. Warnock DW Manual of clinical microbiology, 10th Edition. 2011 10.1128/9781555816728. 13. Ehlers Klug T Rusan M Fuursted K Ovesen T Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark Clin Infect Dis 2009 49 10 1467 72 10.1086/644616 19842975 14. Klug TE Henriksen JJ Fuursted K Ovesen T Significant pathogens in peritonsillar abscesses Eur J Clin Microbiol Infect Dis 2011 30 5 619 27 10.1007/s10096-010-1130-9 21181222 15. Klug TE Henriksen JJ Rusan M Fuursted K Krogfelt KA Ovesen T Struve C Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess Eur J Clin Microbiol Infect Dis 2014 33 10 1733 9 10.1007/s10096-014-2130-y 24810966 16. Klug TE Greve T Andersen C Hahn P Danstrup C Petersen NK Ninn-Pedersen M Mikkelsen S Pauli S Fuglsang S Døssing H Christensen AL Rusan M Kjeldsen A Microbiology of parapharyngeal abscesses in adults: in search of the significant pathogens Eur J Clin Microbiol Infect Dis 2021 40 7 1461 70 10.1007/s10096-021-04180-y 33566204 17. Oliver J Malliya Wadu E Pierse N Moreland NJ Williamson DA Baker MG Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis PLoS Negl Trop Dis 2018 12 3 e0006335 10.1371/journal.pntd.0006335 29554121 18. Klug TE Rusan M Fuursted K Ovesen T Jorgensen AW A systematic review of Fusobacterium necrophorum-positive acute tonsillitis: prevalence, methods of detection, patient characteristics, and the usefulness of the Centor score Eur J Clin Microbiol Infect Dis 2016 35 12 1903 12 10.1007/s10096-016-2757-y 27568201 19. Gunnarsson RK Manchal N Group C beta hemolytic streptococci as a potential pathogen in patients presenting with an uncomplicated acute sore throat - a systematic literature review and meta-analysis Scand J Prim Health Care 2020 38 2 226 37 10.1080/02813432.2020.1753374 32362178 20. Lindbaek M Høiby EA Lermark G Steinsholt IM Hjortdahl P Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A Br J Gen Pract 2005 55 517 615 9 16105370 21. Nygren D Wasserstrom L Holm K Torisson G Associations between Findings of Fusobacterium necrophorum or β-Hemolytic streptococci and complications in Pharyngotonsillitis-A Registry-Based study in Southern Sweden Clin Infect Dis 2023 76 3 e1428 35 10.1093/cid/ciac736 36069108 22. Brook I Foote PA Jr Slots J Jackson W Immune response to Prevotella intermedia in patients with recurrent nonstreptococcal tonsillitis Ann Otol Rhinol Laryngol 1993 102 2 113 6 10.1177/000348949310200207 8427495 23. Brook I Foote PA Jr Slots J Immune response to anaerobic bacteria in patients with peritonsillar cellulitis and abscess Acta Otolaryngol 1996 116 6 888 91 10.3109/00016489609137946 8973727 24. Brook I Deleyva F Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with infectious mononucleosis J Med Microbiol 1996 44 2 131 4 10.1099/00222615-44-2-131 8642574 25. Brook I Foote PA Slots J Immune response to Fusobacterium nucleatum, Prevotella intermedia and other anaerobes in children with acute tonsillitis J Antimicrob Chemother 1997 39 6 763 9 10.1093/jac/39.6.763 9222046 26. Carding S Verbeke K Vipond DT Corfe BM Owen LJ Dysbiosis of the gut microbiota in disease Microb Ecol Health Dis 2015 26 26191 10.3402/mehd.v26.26191 25651997 27. Chimenos-Küstner E Giovannoni ML Schemel-Suárez M Dysbiosis as a determinant factor of systemic and oral pathology: importance of microbiome Med Clin (Barc) 2017 149 7 305 9 10.1016/j.medcli.2017.05.036 28669517 28. Rosenblatt JE Isolation and identification of anaerobic bacteria Hum Pathol 1976 7 2 177 86 10.1016/s0046-8177(76)80021-4 770306 29. Citron DM Appelbaum PC How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay? Clin Infect Dis 1993 16 Suppl 4 435 8 10.1093/clinids/16.supplement_4.s435 8452955 30. Centor RM Atkinson TP Ratliff AE Xiao L Crabb DM Estrada CA Faircloth MB Oestreich L Hatchett J Khalife W Waites KB the clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study Ann Intern Med 2015 162 4 241 7 10.7326/M14-1305 25686164 31. Agerhäll M Henrikson M Johansson Söderberg J Sellin M Tano K Gylfe à Berggren D High prevalence of pharyngeal bacterial pathogens among healthy adolescents and young adults APMIS 2021 129 12 711 6 10.1111/apm.13179 34580908 32. Nygren D Brorson E Musonda M Wasserstrom L Johansson à Holm K Geographical differences in tonsillar carriage rates of Fusobacterium necrophorum - A cross-sectional study in Sweden and Zambia Anaerobe 2021 69 102360 10.1016/j.anaerobe.2021.102360 33757851